Target intelligence / Profile preview

CD4+ T cell receptor recognizing influenza hemagglutinin-derived peptides (HA-specific CD4+ TCR)

Target
HA-specific CD4+ TCR
Molecular classification
T cell receptor, Antigen receptor, Heterodimeric glycoprotein, Immunoglobulin superfamily
01

Overview

The CD4+ T cell receptor (TCR) recognizing influenza hemagglutinin (HA)-derived peptides is a specialized antigen receptor found on the surface of helper T lymphocytes. These receptors specifically identify and bind to peptide fragments of the influenza HA protein, such as the immunodominant HA306-318 epitope, when they are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (PubMed: 25135834). This binding event triggers a signaling cascade through the CD3 complex, leading to T cell activation, proliferation, and the secretion of cytokines like IL-2 and IFN-gamma (Janeway's Immunobiology, 9th Ed). These activated CD4+ T cells play a pivotal role in the immune response by providing essential "help" to B cells for the production of high-affinity neutralizing antibodies and by supporting the generation of memory CD8+ T cells (PubMed: 21844396). In clinical practice, these TCRs are the primary targets of influenza vaccines, which aim to expand the population of HA-specific memory T cells to provide protection against subsequent viral challenges (PubMed: 24037093). However, challenges such as "original antigenic sin" and the high mutation rate of the HA protein can limit the effectiveness of these responses, necessitating the development of vaccines that target more conserved HA epitopes (PubMed: 29305462). Furthermore, cross-reactivity of these TCRs with self-antigens has been implicated in rare adverse events, such as the association between certain flu vaccines and narcolepsy (PubMed: 23520073). Understanding the specificity and diversity of these TCRs is essential for developing universal influenza vaccines and monitoring immune correlates of protection.

Other names
Hemagglutinin-specific T cell receptorHA-reactive CD4+ TCRInfluenza HA-specific T cell receptorHA-specific helper T cell receptor
02

Mechanism of action

Recognition of influenza hemagglutinin peptides presented by MHC class II molecules, triggering intracellular signaling through the CD3 complex to activate helper T cell functions.

03

Biological functions

Antigen recognitionT cell activationImmune response orchestrationB cell helpCytokine production
04

Disease associations

InfectionInfluenza
05

Safety considerations

Original antigenic sin (interference from prior immunity)Molecular mimicry leading to autoimmunity (e.g., narcolepsy association with H1N1 vaccines)Cytokine release syndrome (in extreme over-activation)Immunopathology due to excessive inflammation
06

Interacting drugs

Influenza vaccine (e.g., Fluzone, FluMist, Fluad)

3 more in the full profile.

07

Biomarkers

MHC-peptide tetramer bindingInterferon-gamma (IFN-g) ELISpotIntracellular cytokine staining (ICS) for IL-2/IFN-gTCR repertoire diversity (CDR3 sequencing)CD40L (CD154) expression

Beyond the preview

Go deeper on CD4+ T cell receptor recognizing influenza hemagglutinin-derived peptides (HA-specific CD4+ TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD4+ T cell receptor recognizing influenza hemagglutinin-derived peptides (HA-specific CD4+ TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call